You are reading the October 2026 edition. Get the current edition for this market — $99/year →

Labor Market Pulse

Mankato-North Mankato, MN Metro Edition

Focus: LIFE SCI

Mankato job growth stalls as talent pool keeps shrinking.

3.9%

Mankato unemployment rate

vs 4.1% national, 4.4% Minnesota (July 2026)

+100 jobs

Mankato job growth, August

Down from +500 in July 2026

66.9%

MN labor-force participation

Down from 68.1% a year earlier

1,473 in 2026

Minnesota WARN-affected workers

Down 69% from 2025 levels

This Month's Takeaways

01

Mankato's job growth is stalling, not reversing.

August's 100-job gain follows July's 500, a deceleration that tracks Minnesota's flat statewide employment growth rather than metro-specific weakness. Life Sci employers should not read this as loosening talent supply — unemployment at 3.9% remains tighter than national and state rates.

02

Lab Technician pay is rising locally while falling nationally.

Metro median advertised pay of $42,053 moved up this month even as the national median of $47,402 declined, a divergence that suggests Mankato employers are competing harder for entry-to-mid-level lab talent precisely as national demand cools. This narrowing gap may reduce the cost advantage of a smaller metro for routine lab roles.

03

Twin Cities proximity is Mankato's real talent strategy.

Minneapolis-St. Paul's 16% share of national medtech talent and above-average regional salaries mean Mankato-based organizations are effectively competing in a Twin Cities labor shed for regulatory, quality, and CMC hires. Compensation benchmarking anchored only to local averages risks systematically underpricing these roles.

04

Demographic drag may outlast the current hiring slowdown.

Falling statewide labor-force participation and declining in-migration are structural, not cyclical, pressures on Minnesota's talent pipeline. Headcount planning for specialized functions should assume supply constraints persist even if broader job growth reaccelerates.

Mankato's 3.9% July unemployment rate sits well below the national 4.1% and Minnesota's statewide 4.4%, but the metro's modest 100-job gain in August — a sharp deceleration from July's 500-job add — points to a labor market that has stopped loosening without meaningfully tightening further. Statewide labor-force participation has fallen every month of 2026 to 66.9%, and DEED's own commissioner has flagged an aging workforce and slowing in-migration as structural constraints that compound scarcity for credential-heavy life sciences roles outside the Twin Cities talent base.

A metro this small cannot organically supply specialized regulatory, quality, or CMC talent — Minneapolis-St. Paul's 16% share of national medtech talent makes it the de facto bench for Mankato-based employers, meaning compensation benchmarking should track Twin Cities advertised pay movements, not just local averages. With lab/R&D vacancy running above 23% nationally even as biotech R&D employment hits record levels, build-vs-outsource tradeoffs tilt further toward CRO/CDMO partnerships for roles Mankato cannot realistically staff at scale. Consider reviewing whether current total rewards packages for regulatory and CMC functions reflect Twin Cities commuting-distance competition rather than Mankato MSA's $30.02 average hourly wage baseline.

Advertised Pay Indicators

Role P25 Median P75 Local Trend National Nat. Trend
Research Scientist — — — — No data $131,354 ↑ Significant increase
Clinical Research Associate — — — — No data $90,956 ↑ Significant increase
Lab Technician $40,081 $42,053 $42,346 ↑ Moderate increase $47,402 ↓ Moderate decline
Regulatory Affairs Specialist — — — — No data $104,000 → Stable
Clinical Data Manager — — — — No data $123,031 ↓ Moderate decline
Biostatistician — — — — No data $133,322 ↑ Moderate increase
Validation Engineer — — — — No data $108,377 ↑ Moderate increase

Looking Ahead · Next 30–60 Days

Worth watching

Whether August's slowdown to 100 jobs added becomes a trend or a one-month blip will shape confidence in Mankato as a stable site for R&D or quality headcount expansion. A second weak month would support more conservative local hiring plans.

Emerging pressure point

Minnesota's labor-force participation rate has declined every month of 2026, now at 66.9% versus 68.1% a year ago. Continued erosion narrows the candidate pool for credential-driven manufacturing and quality roles that Mankato-based life sciences employers depend on.

Early indicator

National life sciences job postings rose 20.7% year-over-year in Q2 with pharma manufacturing up 20.8%, a recovery pattern that has not yet shown up distinctly in Mankato metro data. Watch whether this demand surge reaches Minnesota's secondary markets or stays concentrated in the Twin Cities.

Potential inflection point

Minnesota WARN notices affected 69% fewer workers in 2026 than 2025, suggesting limited displaced-talent inflow to absorb. Combined with regional biotech recruiting intensity (64% of surveyed orgs actively hiring), this points to continued competition rather than relief for specialized roles.

WageScape Member Benefit

Monitor more markets, industries, and job families.

Your Pulse covers one metro and one function or industry. Add coverage if you want to see the latest intelligence for other markets, industries, or functions.

Pulse Plus

3 metro reports

$149/year

Pulse Pro

10 metro reports

$349/year

Enterprise

10+ markets

Contact us

WageTrak · 15% Member Discount

On-demand advertised pay data across thousands of job titles, all metro areas, full percentile coverage, and monthly updates. Use code WAGESCAPE15 at wagetrak.com.

Forwarded This Briefing?

Receive your own personalized monthly briefing, filtered to your local market. Scan to enroll below.